Breaking News

Charles River, Bit Bio Enter Strategic Pact

Partnership will leverage Bit Bio’s unique ability to generate authentic human cells at scale

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Charles River Laboratories International, Inc. has entered into an exclusive Discovery and Safety Services partnership with Bit Bio, a company that offers reprogramming of human cells for use in research, drug discovery, and cell therapies.   By applying an engineering approach to synthetic and stem cell biology, Bit Bio has developed technologies for the efficient, consistent, and scalable reprogramming of induced pluripotent stem cells.   Bit Bio’s gene engineering approach, opti-ox (optim...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters